171 related articles for article (PubMed ID: 15611040)
1. X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.
Jozic D; Bourenkov G; Lim NH; Visse R; Nagase H; Bode W; Maskos K
J Biol Chem; 2005 Mar; 280(10):9578-85. PubMed ID: 15611040
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an active form of human MMP-1.
Iyer S; Visse R; Nagase H; Acharya KR
J Mol Biol; 2006 Sep; 362(1):78-88. PubMed ID: 16890240
[TBL] [Abstract][Full Text] [Related]
3. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
[TBL] [Abstract][Full Text] [Related]
4. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
Knäuper V; Bailey L; Worley JR; Soloway P; Patterson ML; Murphy G
FEBS Lett; 2002 Dec; 532(1-2):127-30. PubMed ID: 12459476
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction.
Stricker TP; Dumin JA; Dickeson SK; Chung L; Nagase H; Parks WC; Santoro SA
J Biol Chem; 2001 Aug; 276(31):29375-81. PubMed ID: 11359774
[TBL] [Abstract][Full Text] [Related]
8. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
[TBL] [Abstract][Full Text] [Related]
9. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity.
Freise C; Erben U; Muche M; Farndale R; Zeitz M; Somasundaram R; Ruehl M
Matrix Biol; 2009 Oct; 28(8):480-9. PubMed ID: 19698785
[TBL] [Abstract][Full Text] [Related]
10. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
11. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
Li J; Brick P; O'Hare MC; Skarzynski T; Lloyd LF; Curry VA; Clark IM; Bigg HF; Hazleman BL; Cawston TE
Structure; 1995 Jun; 3(6):541-9. PubMed ID: 8590015
[TBL] [Abstract][Full Text] [Related]
12. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD
Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233
[TBL] [Abstract][Full Text] [Related]
13. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
14. Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).
Nagase H; Suzuki K; Enghild JJ; Salvesen G
Biomed Biochim Acta; 1991; 50(4-6):749-54. PubMed ID: 1666284
[TBL] [Abstract][Full Text] [Related]
15. The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.
Arnold LH; Butt LE; Prior SH; Read CM; Fields GB; Pickford AR
J Biol Chem; 2011 Dec; 286(52):45073-82. PubMed ID: 22030392
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen.
Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T
Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883
[TBL] [Abstract][Full Text] [Related]
17. Activation of type IV procollagenases by human tumor-associated trypsin-2.
Sorsa T; Salo T; Koivunen E; Tyynelä J; Konttinen YT; Bergmann U; Tuuttila A; Niemi E; Teronen O; Heikkilä P; Tschesche H; Leinonen J; Osman S; Stenman UH
J Biol Chem; 1997 Aug; 272(34):21067-74. PubMed ID: 9261109
[TBL] [Abstract][Full Text] [Related]
18. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.
Saarinen J; Kalkkinen N; Welgus HG; Kovanen PT
J Biol Chem; 1994 Jul; 269(27):18134-40. PubMed ID: 8027075
[TBL] [Abstract][Full Text] [Related]
19. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
20. Identification of an Electrostatic Ruler Motif for Sequence-Specific Binding of Collagenase to Collagen.
Subramanian SR; Singam ER; Berinski M; Subramanian V; Wade RC
J Phys Chem B; 2016 Aug; 120(33):8580-9. PubMed ID: 27245212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
